Patients receiving GLP-1s or other weight loss medications often report feeling fuller longer after meals and experiencing fewer urges to snack throughout the day
Weve long known that GLP-1 medications can reduce the risk of heart disease for those with diabetes
Taking a fixed-ratio combination drug leads to a lower risk of weight gain, thanks to the action of GLP-1s
No, they are not the same, but they are in the same class of drugs
(c) anthropometric measurements, such as body weight, BMI, waist circumference (WC), waist-to-hip ratio, visceral adipose tissue (VAT), and subcutaneous adipose tissue (SAT)
A referral might be the most efficient path forward